• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致病性 IgG 自身抗体在实验性自身免疫性肾病中引发和维持的免疫病理事件。

Immunopathological events initiated and maintained by pathogenic IgG autoantibodies in an experimental autoimmune kidney disease.

机构信息

Department of Surgery, University of Calgary, Calgary, Alberta, Canada.

出版信息

Autoimmunity. 2012 Nov;45(7):495-509. doi: 10.3109/08916934.2012.702812. Epub 2012 Aug 17.

DOI:10.3109/08916934.2012.702812
PMID:22816962
Abstract

The experimental models of Heymann nephritis (HN) and slowly progressive Heymann nephritis (SPHN) give us rare opportunities to investigate the etiologies and pathogenesis of two immunopathological processes in rats leading to: (1) autoimmune disease, where the autoimmune disease HN and SPHN is initiated and maintained by cross-reactive pathogenic IgG autoantibodies (aabs) directed against the renal proximal convoluted tubules' brush border (BB) cells - where the nephritogenic antigen (ag) is produced and localized - damaging and releasing BB associated nephritogenic ag into the circulation which in turn contributes to continuation of the autoimmune disease; and (2) immune complex glomerulonephritis, where the glomerular injury is initiated, proceeding into a chronic progressive disease by depositing immune complexes (ICs) - made up of a glomerular epithelial cell produced endogenous nephritogenic ag and the developing pathogenic IgG aab directed against the nephritogenic ag, and complement components - on the epithelial side of the glomerular basement membrane. We also observed how the normally functioning immune system is able to avert autoimmune disease developments by circulating specific non-pathogenic IgM aabs clearing the system of intracytoplasmic ags released from cells at the end of their life spans or following damage by toxic agents. We also described how an autoimmune disease SPHN can be prevented and when present terminated by the implementation of a new vaccination technique we have developed and call modified vaccination technique. By increasing the specific IgM aab production against the native nephritogenic ag - by injecting ICs made up of: [nephritogenic ag X homologous anti-nephritogenic ag IgM ab] in slight ag excess into SPHN rats - pathogenic IgG aab producing native and modified nephritogenic ags were removed from the circulation and termination of the autoimmune disease causing immune events was achieved. Even though HN and SPHN are not well-known disease models, their studies are important because the etiologies and pathogenesis of two conditions - that can also occur in humans, namely autoimmune diseases and membranous glomerulonephritis - can be simultaneously investigated.

摘要

海曼肾炎(HN)和缓慢进展性海曼肾炎(SPHN)的实验模型为我们提供了难得的机会,可研究导致以下两种免疫病理过程的病因和发病机制:(1)自身免疫性疾病,其中自身免疫性疾病 HN 和 SPHN 由针对肾近端曲管刷状缘(BB)细胞的交叉反应性致病性 IgG 自身抗体(aab)启动和维持,该 aab 针对的是产生和局部化肾抗原(ag)的位置,从而损伤并释放与 BB 相关的致肾炎 ag 进入循环,进而有助于自身免疫性疾病的持续;(2)免疫复合物性肾小球肾炎,其中肾小球损伤由产生内源性致肾炎 ag 的肾小球上皮细胞和针对致肾炎 ag 的正在发育的致病性 IgG aab 以及补体成分组成的免疫复合物(ICs)启动,在肾小球基底膜的上皮侧沉积。我们还观察到正常功能的免疫系统如何通过循环特异性非致病性 IgM aab 清除系统中从细胞寿命结束或在受到毒性物质损伤后从细胞内释放的胞内 ag 来避免自身免疫性疾病的发展。我们还描述了如何通过实施我们开发并称为改良疫苗接种技术的新技术来预防和终止自身免疫性疾病 SPHN。通过增加针对天然致肾炎 ag 的特异性 IgM aab 产生-通过向 SPHN 大鼠注射由 [致肾炎 ag X 同源抗致肾炎 ag IgM ab] 组成的 ICs,在轻微的 ag 过量下-致病性 IgG aab 产生的天然和改良致肾炎 ag 被从循环中清除,从而实现了导致免疫事件的自身免疫疾病的终止。尽管 HN 和 SPHN 并不是众所周知的疾病模型,但它们的研究很重要,因为两种疾病的病因和发病机制-也可能发生在人类身上,即自身免疫性疾病和膜性肾小球肾炎-可以同时进行研究。

相似文献

1
Immunopathological events initiated and maintained by pathogenic IgG autoantibodies in an experimental autoimmune kidney disease.致病性 IgG 自身抗体在实验性自身免疫性肾病中引发和维持的免疫病理事件。
Autoimmunity. 2012 Nov;45(7):495-509. doi: 10.3109/08916934.2012.702812. Epub 2012 Aug 17.
2
Antigen-specific down-regulation of immunopathological events in an experimental autoimmune kidney disease.实验性自身免疫性肾病中免疫病理事件的抗原特异性下调
Autoimmun Rev. 2005 Nov;4(8):565-70. doi: 10.1016/j.autrev.2005.04.002.
3
Downregulation of a pathogenic autoantibody response by IgM autoantibodies directed against the nephritogenic antigen in slowly progressive Heymann nephritis.在缓慢进展性海曼肾炎中,针对致肾炎抗原的IgM自身抗体对致病性自身抗体反应的下调作用。
Pathol Int. 2006 Apr;56(4):181-90. doi: 10.1111/j.1440-1827.2006.01944.x.
4
Down-regulation of pathogenic autoantibody response in a slowly progressive Heymann nephritis kidney disease model.在缓慢进展性海曼肾炎肾病模型中致病性自身抗体反应的下调
Int J Exp Pathol. 2004 Dec;85(6):321-34. doi: 10.1111/j.0959-9673.2004.00388.x.
5
Effect of rat kidney fraction 3 (rKF3) antigen and specific IgM antibody against rKF3 on the progression of slowly progressive Heymann nephritis.大鼠肾组分3(rKF3)抗原及抗rKF3特异性IgM抗体对缓慢进行性海曼肾炎进展的影响。
Pathol Int. 2006 Sep;56(9):516-29. doi: 10.1111/j.1440-1827.2006.02000.x.
6
Nephritogenic and non-nephritogenic epithelial antigens in autoimmune and passive Heymann nephritis.自身免疫性和被动型海曼肾炎中的致肾炎性和非致肾炎性上皮抗原
Lab Invest. 1984 Apr;50(4):435-46.
7
Modified vaccination technique for prophylactic and therapeutic applications to combat endogenous antigen-induced disorders.改良疫苗接种技术在预防和治疗内源性抗原诱导疾病中的应用。
Scand J Immunol. 2010 Mar;71(3):125-33. doi: 10.1111/j.1365-3083.2009.02360.x.
8
Presence of immunoglobulin M antibodies around the glomerular capillaries and in the mesangium of normal and passive Heymann nephritis rats.正常及被动型海曼肾炎大鼠肾小球毛细血管周围及系膜中免疫球蛋白M抗体的存在情况。
Int J Exp Pathol. 2004 Oct;85(4):201-12. doi: 10.1111/j.0959-9673.2004.00395.x.
9
Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.抗体诱导海曼抗原在培养的肾小球脏层上皮细胞表面重新分布:在海曼肾小球肾炎发病机制中的可能作用。
J Immunol. 1985 Oct;135(4):2409-16.
10
Preventative and therapeutic vaccination to combat an experimental autoimmune kidney disease.用于对抗实验性自身免疫性肾病的预防性和治疗性疫苗接种。
Biologics. 2007 Mar;1(1):59-68.

引用本文的文献

1
MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis.微小RNA作为治疗肾损伤和纤维化的新型治疗靶点。
Am J Physiol Renal Physiol. 2016 May 1;310(10):F931-44. doi: 10.1152/ajprenal.00523.2015. Epub 2016 Feb 24.
2
Regaining tolerance to a self-antigen by the modified vaccination technique.通过改良接种技术恢复对自身抗原的耐受性。
Clin Rev Allergy Immunol. 2013 Oct;45(2):193-201. doi: 10.1007/s12016-012-8350-y.